In vitro and in vivo evaluation of self-assembled chitosan nanoparticles selectively overcoming hepatocellular carcinoma via asialoglycoprotein receptor

References

• Bakshi PS, Selvakumar D, Kadirvelu K, Kumar NS. (2020). Chitosan as an environment friendly biomaterial – a review on recent modifications and applications. Int J Biol Macromol 150:1072–83.
   PubMed Web of Science ®Google Scholar
• Barbosa HFG, Attjioui M, Leitao A, et al. (2019). Characterization, solubility and biological activity of amphihilic biopolymeric Schiff bases synthesized using chitosans. Carbohydr Polym 220:1–11.
   PubMed Web of Science ®Google Scholar
• Bonferoni MC, Gavini E, Rassu G, et al. (2020). Chitosan nanoparticles for therapy and theranostics of hepatocellular carcinoma (HCC) and liver-targeting. Nanomaterials 10:870.
   Web of Science ®Google Scholar
• Dai Q, Zhang C, Yuan Z, et al. (2020). Current discovery strategies for hepatocellular carcinoma therapeutics. Expert Opin Drug Discov 15:243–58.
   PubMed Web of Science ®Google Scholar
• Dong H, Tian L, Gao M, et al. (2017). Promising galactose-decorated biodegradable poloxamer 188-PLGA diblock copolymer nanoparticles of resibufogenin for enhancing liver cancer therapy. Drug Deliv 24:1302–16.
   PubMed Web of Science ®Google Scholar
• D'Souza AA, Devarajan PV. (2015). Asialoglycoprotein receptor mediated hepatocyte targeting – strategies and applications. J Control Release 203:126–39.
   PubMed Web of Science ®Google Scholar
• Gagic Z, Ivkovic B, Srdic-Rajic T, et al. (2016). Synthesis of the vitamin E amino acid esters with an enhanced anticancer activity and in silico screening for new antineoplastic drugs. Eur J Pharm Sci 88:59–69.
   PubMed Web of Science ®Google Scholar
• Guo H, Zhang D, Li C, et al. (2013). Self-assembled nanoparticles based on galactosylated O-carboxymethyl chitosan-graft-stearic acid conjugates for delivery of doxorubicin. Int J Pharm 458:31–8.
   PubMed Web of Science ®Google Scholar
• Huang Y, Hu L, Huang S, et al. (2018). Curcumin-loaded galactosylated BSA nanoparticles as targeted drug delivery carriers inhibit hepatocellular carcinoma cell proliferation and migration. Int J Nanomedicine 13:8309–23.
   PubMed Web of Science ®Google Scholar
• Ikeda M, Morizane C, Ueno M, et al. (2018). Chemotherapy for hepatocellular carcinoma: current status and future perspectives. Jpn J Clin Oncol 48:103–14.
   PubMed Web of Science ®Google Scholar
• Khemlina G, Ikeda S, Kurzrock R. (2017). The biology of hepatocellular carcinoma: implications for genomic and immune therapies. Mol. Cancer 16:149.
   PubMed Web of Science ®Google Scholar
• Li GF, Zhao MM, Zhao LM. (2020). Lysine-mediated hydroxyethyl starch-10-hydroxy camptothecin micelles for the treatment of liver cancer. Drug Deliv 27:519–29.
   PubMed Web of Science ®Google Scholar
• Liao X, Bu Y, Jia QG. (2020). Traditional Chinese medicine as supportive care for the management of liver cancer: past, present, and future. Genes Dis 7:370–9.
   PubMed Web of Science ®Google Scholar
• Lou S, Zhang X, Zhang M, et al. (2017). Preparation of a dual cored hepatoma-specific star glycopolymer nanogel via arm-first ATRP approach. Int J Nanomedicine 12:3653–64.
   PubMed Web of Science ®Google Scholar
• Nair AB, Shah J, Al-Dhubiab BE, et al. (2019). Development of asialoglycoprotein receptor-targeted nanoparticles for selective delivery of gemcitabine to hepatocellular carcinoma. Molecules 24:4566.
   PubMed Web of Science ®Google Scholar
• Narsinh KH, Duncan DP, Newton IG, et al. (2018). Liver-directed therapy for hepatocellular carcinoma. Abdom Radiol (NY) 43:203–17.
   PubMed Web of Science ®Google Scholar
• Pan Z, Gao Y, Heng L, et al. (2013). Amphiphilic N-(2,3-dihydroxypropyl)-chitosan-cholic acid micelles for paclitaxel delivery. Carbohydr Polym 94:394–9.
   PubMed Web of Science ®Google Scholar
• Qi X, Rui Y, Fan Y, et al. (2015). Galactosylated chitosan-grafted multiwall carbon nanotubes for pH-dependent sustained release and hepatic tumor-targeted delivery of doxorubicin in vivo. Colloids Surf B Biointerfaces 133:314–22.
   PubMed Web of Science ®Google Scholar
• Qi YJ, Liu GX. (2021). Berberine-10-hydroxy camptothecine-loaded lipid microsphere for the synergistic treatment of liver cancer by inhibiting topoisomerase and HIF-1α. Drug Deliv 28:171–82.
   PubMed Web of Science ®Google Scholar
• Quinones JP, Peniche H, Peniche C. (2018). Chitosan based self-assembled nanoparticles in drug delivery. Polymers 10:235.
   PubMed Web of Science ®Google Scholar
• Raoul JL, Edeline J. (2020). Systemic treatment of hepatocellular carcinoma: standard of care in China and elsewhere. Lancet Oncol 21:479–81.
   PubMed Web of Science ®Google Scholar
• Richard I, Thibault M, De Crescenzo G, et al. (2013). Ionization behavior of chitosan and chitosan-DNA polyplexes indicate that chitosan has a similar capability to induce a proton-sponge effect as PEI. Biomacromolecules 14:1732–40.
   PubMed Web of Science ®Google Scholar
• Sun Y, Zhang J, Han J, et al. (2017). Galactose-containing polymer-DOX conjugates for targeting drug delivery. AAPS PharmSciTech 18:749–58.
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, et al. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clin 71:209–49.
   PubMed Web of Science ®Google Scholar
• Vermeulen LMP, De Smedt SC, Remaut K, Braeckmans K. (2018). The proton sponge hypothesis: fable or fact? Eur J Pharm Biopharm 129:184–90.
   PubMed Web of Science ®Google Scholar
• Wang C, Zhang Z, Chen B, et al. (2018). Design and evaluation of galactosylated chitosan/graphene oxide nanoparticles as a drug delivery system. J Colloid Interface Sci 516:332–41.
   PubMed Web of Science ®Google Scholar
• Wang Q, Zhang L, Hu W, et al. (2010). Norcantharidin-associated galactosylated chitosan nanoparticles for hepatocyte-targeted delivery. Nanomedicine 6:371–81.
   PubMed Web of Science ®Google Scholar
• Xiang Y, Huang W, Huang C, et al. (2020). Facile fabrication of nanoparticles with dual-targeting ligands for precise hepatocellular carcinoma therapy in vitro and in vivo. Mol Pharm 17:3223–35.
   PubMed Web of Science ®Google Scholar
• Xiao L, Yu E, Yue H, Li Q. (2019). Enhanced liver targeting of camptothecin via conjugation with deoxycholic acid. Molecules 24: 1179.
   PubMed Web of Science ®Google Scholar
• Zhai Q, Li H, Song Y, et al. (2018). Preparation and optimization lipid nanocapsules to enhance the antitumor efficacy of cisplatin in hepatocellular carcinoma HepG2 cells. AAPS PharmSciTech 19:2048–57.
   PubMed Web of Science ®Google Scholar
• Zhang E, Xing R, Liu S, et al. (2019). Advances in chitosan-based nanoparticles for oncotherapy. Carbohydr Polym 222: 115004.
   PubMed Web of Science ®Google Scholar
• Zhang P, Cao M. (2014). Preparation of a novel organo-soluble chitosan grafted polycaprolactone copolymer for drug delivery. Int J Biol Macromol 65:21–7.
   PubMed Web of Science ®Google Scholar
• Zhang YQ, Shen Y, Liao MM, et al. (2019). Galactosylated chitosan triptolide nanoparticles for overcoming hepatocellular carcinoma: enhanced therapeutic efficacy, low toxicity, and validated network regulatory mechanisms. Nanomedicine 15:86–97.
   PubMed Web of Science ®Google Scholar
• Zheng QC, Jiang S, Wu YZ, et al. (2020). Dual-targeting nanoparticle-mediated gene therapy strategy for hepatocellular carcinoma by delivering small interfering RNA. Front Bioeng Biotech 8: 512.
   PubMed Web of Science ®Google Scholar
• Zhou H, Yu W, Guo X, et al. (2010). Synthesis and characterization of amphiphilic glycidol-chitosan-deoxycholic acid nanoparticles as a drug carrier for doxorubicin. Biomacromolecules 11:3480–6.
   PubMed Web of Science ®Google Scholar